<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Espinosa S</submitter><funding>National Institute of General Medical Sciences of the National Institute of Health</funding><funding>National Institutes of Health</funding><funding>Howard Hughes Medical Institute Gilliam Fellow</funding><funding>NIGMS NIH HHS</funding><funding>the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases</funding><pubmed_abstract>Human PRPF39 is a homolog of the yeast Prp39 and Prp42 paralogs. We have previously shown that human PRPF39 forms a homodimer that interacts with the CTD of U1C, mirroring the yeast Prp39/Prp42 heterodimer. We demonstrate here that PRPF39 knockdown in HEK293 cells affects many alternative splicing events primarily by reducing the usage of weak 5'ss. Additionally, PRPF39 preferentially binds to a GC-rich RNA, likely at the interface between its NTD and CTD. These data indicate that PRPF39 potentially recruits U1 snRNP to a weak 5' ss, serving as a previously unrecognized alternative splicing factor. We further demonstrate that human TIA1 binds to U1C through its RRM1 and RRM3+Q domains but has no significant binding to PRPF39. Finally, all three human LUC7L isoforms directly interact with U</pubmed_abstract><journal>RNA (New York, N.Y.)</journal><pagination>rna.079320.122</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9808567</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sites.</pubmed_title><pmcid>PMC9808567</pmcid><funding_grant_id>R01 GM129325</funding_grant_id><funding_grant_id>R35 GM133385</funding_grant_id><funding_grant_id>T32GM008730</funding_grant_id><funding_grant_id>F32GM145067</funding_grant_id><funding_grant_id>R01-GM129325</funding_grant_id><funding_grant_id>T32 GM008730</funding_grant_id><funding_grant_id>R35GM133385</funding_grant_id><funding_grant_id>R35 GM145289</funding_grant_id><funding_grant_id>R01GM126157</funding_grant_id><funding_grant_id>R01 GM126157</funding_grant_id><funding_grant_id>F32 GM145067</funding_grant_id><funding_grant_id>R35GM145289</funding_grant_id><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Wagley ME</pubmed_authors><pubmed_authors>De Bortoli F</pubmed_authors><pubmed_authors>Rossi J</pubmed_authors><pubmed_authors>Zhao R</pubmed_authors><pubmed_authors>Espinosa S</pubmed_authors><pubmed_authors>Lo HG</pubmed_authors><pubmed_authors>Taliaferro JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sites.</name><description>Human PRPF39 is a homolog of the yeast Prp39 and Prp42 paralogs. We have previously shown that human PRPF39 forms a homodimer that interacts with the CTD of U1C, mirroring the yeast Prp39/Prp42 heterodimer. We demonstrate here that PRPF39 knockdown in HEK293 cells affects many alternative splicing events primarily by reducing the usage of weak 5'ss. Additionally, PRPF39 preferentially binds to a GC-rich RNA, likely at the interface between its NTD and CTD. These data indicate that PRPF39 potentially recruits U1 snRNP to a weak 5' ss, serving as a previously unrecognized alternative splicing factor. We further demonstrate that human TIA1 binds to U1C through its RRM1 and RRM3+Q domains but has no significant binding to PRPF39. Finally, all three human LUC7L isoforms directly interact with U</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-05-28T02:14:39.746Z</modification><creation>2025-04-06T19:19:31.388Z</creation></dates><accession>S-EPMC9808567</accession><cross_references><pubmed>36316087</pubmed><doi>10.1261/rna.079320.122</doi></cross_references></HashMap>